- Home
- AUPH vs PGNY Comparison
AUPH vs PGNY Comparison
Compare AUPH & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | PGNY |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AUPH | PGNY |
|---|---|---|
| Price | $14.34 | $18.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $17.25 | ★ $27.80 |
| AVG Volume (30 Days) | 857.6K | ★ 1.6M |
| Earning Date | 05-25-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 14.04 |
| EPS | ★ 2.07 | 0.65 |
| Revenue | $283,055,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $17.35 | $9.57 |
| Revenue Next Year | $15.66 | $10.06 |
| P/E Ratio | ★ $7.11 | $27.21 |
| Revenue Growth | ★ 20.38 | 10.40 |
| 52 Week Low | $6.83 | $16.76 |
| 52 Week High | $16.54 | $28.75 |
Technical Indicators
Market Signals| Indicator | AUPH | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 34.24 |
| Support Level | $13.52 | $18.01 |
| Resistance Level | $16.28 | $23.34 |
| Average True Range (ATR) | 0.54 | 1.02 |
| MACD | 0.05 | -0.17 |
| Stochastic Oscillator | 46.51 | 27.35 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.